Dosage forms with improved bioavailability

A solid dispersion product comprising an effective amount of one or more active ingredients and an effective amount of one or more hydroxypropyl methylcellulose(s), which satisfies the Formula 0.35> Htr (1) (wherein AHtr represents the endotherm (J/g) accompanying a transition at about 240° C.)....

Full description

Saved in:
Bibliographic Details
Main Authors MAEGERLEIN MARKUS, DEGENHARDT MATTHIAS, BERNDL GUNTHER
Format Patent
LanguageEnglish
Published 23.06.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A solid dispersion product comprising an effective amount of one or more active ingredients and an effective amount of one or more hydroxypropyl methylcellulose(s), which satisfies the Formula 0.35> Htr (1) (wherein AHtr represents the endotherm (J/g) accompanying a transition at about 240° C.). The solid dispersion product is used for the manufacture of a dosage form having improved bioavailability of said one or more active ingredients by oral administration to a patient in need thereof.
Bibliography:Application Number: US201113165398